Overview

Chemistry, Manufacturing, and Controls (CMC) together with GMP systems are essential for ensuring the quality, safety, consistency, and regulatory compliance of biopharmaceutical products throughout development and manufacturing. As biologics pipelines continue to expand, developers face increasing challenges in raw material qualification, analytical method development, process consistency, quality control, and scalable GMP manufacturing. At ACROBiosystems, we provide integrated CMC and GMP support solutions covering key stages from early development to clinical manufacturing, including GMP-grade proteins, raw materials, analytical reagents, quality control tools, functional assays, and regulatory-oriented support — helping accelerate biopharmaceutical development with reliable quality systems and high-standard reagents.
Overview

Resources

Comprehensive Quality Control Solution for Biologics

Comprehensive Quality Control Solution for Biologics

Request PDF
Solutions of Immune Cell Therapy Development

Solutions of Immune Cell Therapy Development

Request PDF
Make the Transition Into GMP

Make the Transition Into GMP

Request PDF
SAFENSURE™ De-risking Safety Testing Solutions for Biologics

SAFENSURE™ De-risking Safety Testing Solutions for Biologics

Request PDF
Comprehensive Quality Control Solution for Biologics

Comprehensive Quality Control Solution for Biologics

Request PDF
Solutions of Immune Cell Therapy Development

Solutions of Immune Cell Therapy Development

Request PDF
Make the Transition Into GMP

Make the Transition Into GMP

Request PDF
SAFENSURE™ De-risking Safety Testing Solutions for Biologics

SAFENSURE™ De-risking Safety Testing Solutions for Biologics

Request PDF

Webinars

webinar
play
webinar
play
webinar
play
webinar
play
webinar
play
webinar
play

Frequently Asked Questions

Q

How can early CMC planning reduce development risk?

Early CMC planning can reduce development risk by building a more stable manufacturing and quality foundation before late-stage clinical development. By starting process characterization and analytical method development early, developers can better assess scalability, comparability, and product consistency. Early supplier qualification and the use of high-quality materials can also help avoid costly re-validation or equivalency studies during clinical transition. Proactive risk assessment and regulatory documentation further reduce the likelihood of late-stage manufacturing disruptions or submission delays.
Q

How does GMP help ensure quality and compliance?

Good Manufacturing Practice provides a structured framework for quality, consistency, and compliance in biopharmaceutical development. GMP covers key areas such as raw material control, facility hygiene, validated production processes, batch records, traceability, and analytical testing. These controls help reduce the risk of contamination, process errors, and batch variability. Instead of relying only on final product testing, GMP emphasizes controlled processes and preventive risk management to support product safety and reliability.
Q

What is the role of CMC in biopharmaceutical development?

CMC, or Chemistry, Manufacturing, and Controls, is a critical bridge between early-stage discovery and clinical application. Rather than being only late-stage documentation, CMC provides the quality framework that supports the entire development lifecycle. It connects process development, formulation, stability studies, analytical methods, and quality control. A strong CMC strategy helps ensure that the manufacturing process is robust, scalable, and capable of producing consistent batches, while also providing the data required for regulatory submissions.

Explore More Topics

Cell and Gene Therapy

Cell and Gene Therapy

Antibody-Drug Conjugates

Antibody-Drug Conjugates

Bispecific Antibodies

Bispecific Antibodies

Disease Areas

Disease Areas

Vaccines

Vaccines

Research & Innovation

Research & Innovation

Contact Us

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8